2,5-Dioxopyrrolidin-1-yl 3-(2-(2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)propanoate

Catalog No. :
ACEGCI038
CAS No. :
955094-26-5
Molecular Formula :
C18H23N3O9
Molecular Weight :
425.39

IUPAC Name:Mal-amido-PEGn-NHS

2,5-Dioxopyrrolidin-1-yl 3-(2-(2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)propanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$79.00Login to see priceIn stockInquiry
5g95%$259.00Login to see priceIn stockInquiry
25g95%$965.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5-Dioxopyrrolidin-1-yl 3-(2-(2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)propanoate
IUPAC NameMal-amido-PEGn-NHS
MDL No.MFCD11041137
Molecular FormulaC18H23N3O9
Molecular Weight425.39
SMILESO=C(ON1C(CCC1=O)=O)CCOCCOCCNC(CCN2C(C=CC2=O)=O)=O
InChI KeyTZPDZOJURBVWHS-UHFFFAOYSA-N
SynonymMaleimide-PEG2-NHS | Maleimidopropionyl-PEG2-NHS Ester | 3-[2-[2-[[3-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]amino]ethoxy]ethoxy]propanoic acid 2,5-dioxo-1-pyrrolidinyl ester | Succinimide-Maleimide PEG
CAS No.955094-26-5
PubChem CID51340948

Synthetic Route by SureRoute

1. ACEGCI038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVDH752 route compound structure diagram
    ACQVDH752756525-98-1 In Stock
  2. Plus
  3. ACPOQL635 route compound structure diagram
    ACPOQL6356066-82-6 In Stock
  4. Then
  5. ACEGCI038 route product structure diagram
    ACEGCI038955094-26-5 In Stock
Inquiry

2. ACEGCI038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHMLB092 route compound structure diagram
    ACHMLB0927423-55-4 In Stock
  4. Then
  5. ACEGCI038 route product structure diagram
    ACEGCI038955094-26-5 In Stock
Inquiry

Comments (0)